Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

83.85
Delayed Data
As of 4:00pm ET
 -1.13 / -1.33%
Today’s Change
78.50
Today|||52-Week Range
100.51
-5.97%
Year-to-Date

Today’s Trading

Previous close84.98
Today’s open81.77
Day’s range81.77 - 85.03
Volume828,454
Average volume (3 months)1,329,683
Market cap$14.9B
Data as of 4:00pm ET, 02/20/2018

Growth & Valuation

Earnings growth (last year)-256.07%
Earnings growth (this year)+82.98%
Earnings growth (next 5 years)+21.00%
Revenue growth (last year)+27.18%
P/E ratioNM
Price/Sales12.40
Price/Book5.30

Competitors

 Today’s
change
Today’s
% change
MYLMylan NV-0.80-1.90%
PRGOPerrigo Company PLC-2.51-2.80%
JAZZJazz Pharmaceuticals...-0.98-0.67%
ALNYAlnylam Pharmaceutic...-2.05-1.67%
Data as of 4:15pm ET, 02/20/2018

Financials

Next reporting dateFebruary 22, 2018
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$1.1B
Annual profit (last year)-$630.2M
Net profit margin-56.74%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Jean-Jacques Bienaimé
Chief Financial Officer &
Executive Vice President
Dan Spiegelman
Corporate headquarters
San Rafael, California

Forecasts